TGM2 and cancer: In the last years, evidence has been provided that human TG4 and TG2 are alternatively spliced in prostate tissues and that alternative splicing processes occur in association with loss of prostate tissue homeostasis and transition towards pathological states, i.e., inflammatory conditions and cancer.